# Bioequivalence Study of 3 mg Glimepiride Tablet in Indonesia Healthy Subjects

> **NCT05468879** · NA · COMPLETED · sponsor: **PT Harsen Laboratories** · enrollment: 34 (actual)

## Conditions studied

- Drug Use

## Interventions

- **DRUG:** Glimepiride
- **DRUG:** Amaryl®

## Key facts

- **NCT ID:** NCT05468879
- **Lead sponsor:** PT Harsen Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-21
- **Primary completion:** 2020-10-23
- **Final completion:** 2021-01-06
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2022-07-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05468879

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05468879, "Bioequivalence Study of 3 mg Glimepiride Tablet in Indonesia Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05468879. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*